23 May 2013
Keywords: AstraZeneca, Brilique, Germany, Blood thinner,
Article | 16 December 2011
The German health assessment body, the Federal Joint Committee (G-BA), has issued its final decision regarding the medical benefit of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 December 2011
15 December 2011
22 May 2013
© 2013 thepharmaletter.com